Le Lézard
Classified in: Health
Subjects: NPT, SVY, HSP, ASI, BLK, LGB, NTA, DEI

Diverse, Inclusive Data Leads to Better Health Outcomes and Healthier Communities


Blue Cross Blue Shield Association and National Minority Quality Forum partner to improve data collection on race, ethnicity, language, sexual orientation and gender identity

WASHINGTON, March 28, 2023 /PRNewswire/ -- Today, the Blue Cross Blue Shield Association (BCBSA) in partnership with the National Minority Quality Forum (NMQF) is proud to release recommendations for improving and standardizing data collection methods around race, ethnicity, and language (REL) and sexual orientation and gender identity (SOGI) to reduce health disparities and increase access to higher-quality care for underserved populations.

Significant inequities exist throughout the U.S. health care system, resulting in preventable negative health outcomes for historically marginalized racial, ethnic, socioeconomic, and LGBTQ+ communities. The lack of comprehensive data as well as outdated standards for collecting information are contributing factors to the growing health equity gap.

"Data is more than numbers?it represents people. Our data must be as diverse and inclusive as our nation's population," said BCBSA President and CEO Kim Keck. "Standardized, precise data provide opportunities for insurers, health care providers and patient advocates to design and implement targeted health solutions to better meet the needs of disproportionately impacted communities. Through the adoption of comprehensive data collection standards, we can address health inequities head on and create a better system of health for all Americans." 

In 1977, the Office of Management and Budget (OMB) introduced Statistical Policy Directive No. 15 that established a set of minimum standards to ensure the federal government's ability to compare information and data across federal agencies, as well as document the effectiveness of federal programs in serving the diverse populations. This directive was last updated in 1997 to encourage further standards for maintaining, collecting and presenting data on race and ethnicity. Now almost 30 years later, OMB is initiating a formal review to revise the directive by the summer of 2024.

BCBSA and NMQF recommend the following solutions be included in the updated directive:

"High-quality, reliable data are essential to understanding where and how health disparities arise," said NMQF President and CEO Dr. Gary A. Puckrein. "Sufficiently collecting and exchanging data requires a multi-stakeholder approach and we look forward to working with players in the public and private sectors to establish a robust set of data standards and ultimately reduce health equities in the United States."

About Blue Cross Blue Shield Association The Blue Cross and Blue Shield Association is a national federation of 34 independent, community-based and locally operated Blue Cross and Blue Shield companies that collectively provide health care coverage for one in three Americans.

About National Minority Quality Forum The National Minority Quality Forum (NMQF) is a 501(c)(3) not-for-profit research and advocacy organization based in Washington, DC. The mission of NMQF is to reduce patient risk by assuring optimal care for all. NMQF's vision is an American health services research, delivery and financing system whose operating principle is to reduce patient risk for amenable morbidity and mortality while improving quality of life. For more information, please visit www.nmqf.org.

SOURCE Blue Cross Blue Shield Association


These press releases may also interest you

at 17:25
Talphera, Inc. , ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted...

at 16:56
A paper published in the June edition of the Journal Diabetes demonstrates that C-peptide, a biomarker that indicates the production of insulin, is a validated surrogate endpoint, or predictor of clinical benefit, for clinical trials of...

at 16:28
?Patients Treated with ARIKAYCE Plus Macrolide-Based Background Regimen Had Meaningfully Greater Improvements in Respiratory Symptoms vs. Macrolide-Based Background Regimen Alone, As Measured By the QOL-B Respiratory Domain Instrument? ?QOL-B...

at 16:20
Jarrard Inc., a leading national healthcare strategic communications consultancy, has expanded by 10 percent, adding seven new professionals to address the increasing demand for its healthcare advisory services. The team now includes 81 full-time...

at 16:10
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has determined a new record...

at 16:10
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of...



News published on and distributed by: